CSL Seqirus

CSL Seqirus is one of the world's largest influenza vaccine providers and a major contributor to global pandemic preparedness. A subsidiary of CSL Limited, the company operates a state-of-the-art manufacturing network across three continents, utilizing egg-based, cell-based, and adjuvant technologies to produce a broad portfolio of seasonal and pandemic vaccines. The company is a leader in the transition toward next-generation vaccine platforms, including self-amplifying mRNA (sa-mRNA) and cell-based manufacturing. It serves as a critical partner to governments and health authorities worldwide, including the U.S. BARDA and the European Commission, to ensure rapid response capabilities for emerging infectious disease threats.